Treatment of Exudative Age-related Macular Degeneration: Focus on Aflibercept
about
Evaluation of Aflibercept Treatment Responses in Eyes with Bevacizumab/Ranibizumab-resistant Wet Age-related Macular Degeneration.EGHB010, a Standardized Extract of Paeoniae Radix and Glycyrrhizae Radix, Inhibits VEGF-Induced Tube Formation In Vitro and Retinal Vascular Leakage and Choroidal Neovascularization In Vivo.Aster koraiensis Extract and Chlorogenic Acid Inhibit Retinal Angiogenesis in a Mouse Model of Oxygen-Induced Retinopathy.
P2860
Treatment of Exudative Age-related Macular Degeneration: Focus on Aflibercept
description
2015 nî lūn-bûn
@nan
2015 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Treatment of Exudative Age-related Macular Degeneration: Focus on Aflibercept
@ast
Treatment of Exudative Age-related Macular Degeneration: Focus on Aflibercept
@en
Treatment of Exudative Age-related Macular Degeneration: Focus on Aflibercept
@nl
type
label
Treatment of Exudative Age-related Macular Degeneration: Focus on Aflibercept
@ast
Treatment of Exudative Age-related Macular Degeneration: Focus on Aflibercept
@en
Treatment of Exudative Age-related Macular Degeneration: Focus on Aflibercept
@nl
prefLabel
Treatment of Exudative Age-related Macular Degeneration: Focus on Aflibercept
@ast
Treatment of Exudative Age-related Macular Degeneration: Focus on Aflibercept
@en
Treatment of Exudative Age-related Macular Degeneration: Focus on Aflibercept
@nl
P2093
P2860
P921
P1433
P1476
Treatment of Exudative Age-related Macular Degeneration: Focus on Aflibercept
@en
P2093
Alfredo García-Layana
Francisco Gómez-Ulla
Javier Araiz
José M Ruiz-Moreno
Luis Arias-Barquet
Marta S Figueroa
Nicholas Reiter
P2860
P2888
P304
P356
10.1007/S40266-015-0300-Y
P407
P5008
P577
2015-10-01T00:00:00Z
P5875
P6179
1010256240